Identification of gp96 as a novel target for treatment of autoimmune disease in mice

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Han, Jung Min ^a   Kwon, Nam Hoon ^a   Lee, Jin Young ^a   Jeong, Seung Jae ^a   Jung, Hee Jung ^c   Kim, Hyeong Rae ^c   Li, Zihai ^d   Kim, Sunghoon ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOPLASMIN; MEMBRANE PROTEIN;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; C57BL MOUSE; CELL MEMBRANE; CYTOLOGY; DENDRITIC CELL; DISEASE MODEL; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PHENOTYPE; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL MEMBRANE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; SPLEEN; T-LYMPHOCYTES;

EID: 77953621880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009792     Document Type: Article

References (42)

1. Monrad S, Kaplan MJ (2007) Dendritic cells and the immunopathogenesis of systemic lupus erythematosus. Immunol Res 37: 135-145.
2. Nagy G, Koncz A, Perl A (2005) T-and B-cell abnormalities in systemic lupus erythematosus. Crit Rev Immunol 25: 123-140.
3. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez C, Abbas AK (1994) Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol 6: 913-920.
4. Wakeland EK, Wandstrat AE, Liu K, Morel L (1999) Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 11: 701-707.
5. Chatham WW, Kimberly RP (2001) Treatment of lupus with corticosteroids. Lupus 10: 140-147.
6. Li Z, Dai J, Zheng H, Liu B, Caudill M (2002) An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response. Front Biosci 7: d731-751.
7. Pelham HR (1991) Recycling of proteins between the endoplasmic reticulum and Golgi complex. Curr Opin Cell Biol 3: 585-591.
8. Letourneur F, Gaynor EC, Hennecke S, Demolliere C, Duden R, et al. (1994) Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell 79: 1199-1207.
9. Wieland F, Harter C (1999) Mechanisms of vesicle formation: insights from the COP system. Curr Opin Cell Biol 11: 440-446.
10. Barlowe C (2000) Traffic COPs of the early secretory pathway. Traffic 1: 371-377.
11. Semenza JC, Hardwick KG, Dean N, Pelham HR (1990) ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway. Cell 61: 1349-1357.
12. Griffiths G, Ericsson M, Krijnse-Locker J, Nilsson T, Goud B, et al. (1994) Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells. J Cell Biol 127: 1557-1574.
13. Majoul I, Straub M, Hell SW, Duden R, Soling HD (2001) KDEL-cargo regulates interactions between proteins involved in COPI vesicle traffic: measurements in living cells using FRET. Dev Cell 1: 139-153.
14. Lewis MJ, Pelham HR (1992) Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell 68: 353-364.
15. Majoul I, Sohn K, Wieland FT, Pepperkok R, Pizza M, et al. (1998) KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p. J Cell Biol 143: 601-612.
16. Neve EP, Lahtinen U, Pettersson RF (2005) Oligomerization and interacellular localization of the glycoprotein receptor ERGIC-53 is independent of disulfide bonds. J Mol Biol 354: 556-568.
17. Nemoto T, Sato N (1998) Oligomeric forms of the 90-kDa heat shock protein. Biochem J 330(Pt 2): 989-995.
18. Dollins DE, Warren JJ, Immormino RM, Gewirth DT (2007) Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones. Mol Cell 28: 41-56.
19. Chadli A, Ladjimi MM, Baulieu EE, Catelli MG (1999) Heat-induced oligomerization of the molecular chaperone Hsp90. Inhibition by ATP and geldanamycin and activation by transition metal oxyanions. J Biol Chem 274: 4133-4139.
20. Srivastava P (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20: 395-425.
21. Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2: 185-194.
22. Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, et al. (2002) Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 99: 3676-3682.
23. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12: 1539-1546.
24. Banerjee PP, Vinay DS, Mathew A, Raje M, Parekh V, et al. (2002) Evidence that glycoprotein 96 (B2), a stress protein, functions as a Th2-specific costimulatory molecule. J Immunol 169: 3507-3518.
25. Binder RJ, Han DK, Srivastava PK (2000) CD91: a receptor for heat shock protein gp96. Nat Immunol 1: 151-155.
26. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
27. Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, et al. (2002) The ERresident heat shock protein Gp96 activates dendritic cells via the TLR2/4 pathway. J Biol Chem.
28. Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee HG, et al. (2000) The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30: 2211-2215.
29. Liu B, Dai J, Zheng H, Stoilova D, Sun S, et al. (2003) Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A 100: 15824-15829.
30. Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM, 2nd, et al. (2009) Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol 182: 4965-4973.
31. Lee SWKG, Kim S (2008) Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43: an emerging therapeutic protein working at systems level. Exp Opinion Drug Discovery 3: 945-957.
32. Han JM, Park SG, Liu B, Park BJ, Kim JY, et al. (2007) Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein 1/p43 Controls Endoplasmic Reticulum Retention of Heat Shock Protein gp96: Its Pathological Implications in Lupus-Like Autoimmune Diseases. Am J Pathol 170: 2042-2054.
33. Kunst CB, Mezey E, Brownstein MJ, Patterson D (1997) Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 15: 91-94.
34. Teague SJ, Davis AM, Leeson PD, Oprea T (1999) The Design of Leadlike Combinatorial Libraries. Angew Chem Int Ed Engl 38: 3743-3748.
35. Robert J, Menoret A, Cohen N (1999) Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. J Immunol 163: 4133-4139.
36. Schur PH (1995) Genetics of systemic lupus erythematosus. Lupus 4: 425-437.
37. Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56: 481-490.
38. Bjork P, Bjork A, Vogl T, Stenstrom M, Liberg D, et al. (2009) Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol 7: e97.
39. Neubert K, Meister S, Moser K, Weisel F, Maseda D, et al. (2008) The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14: 748-755.
40. Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, et al. (2005) PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11: 933-935.
41. Johnson KM, Chen X, Boitano A, Swenson L, Opipari AW, Jr., et al. (2005) Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem Biol 12: 485-496.
42. Berden JH, Hang L, McConahey PJ, Dixon FJ (1983) Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J Immunol 130: 1699-1705.